Shamburg News · 8-K filed Nov 13, 2026, 4:05 PM EST

TherapeuticsMD Reports Third Quarter 2026 Net Income of $501 Thousand

TXMD · TherapeuticsMD, Inc.

  • Earnings
  • Other event
  • Materiality: high

TherapeuticsMD, Inc. reported net income from continuing operations of $501 thousand, or $0.04 per basic and diluted share, for the three months ended September 30, 2026, compared with $50 thousand, or $0.00 per share, a year earlier. License revenue was $1.3 million, up 60.6% from $784 thousand, and total operating expenses were $1.7 million. The company also said it continues to evaluate strategic alternatives and had $10.4 million in cash and cash equivalents as of September 30, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 7.01, accession 0001213900-26-119681.

Written from the filing by Shamburg Markets. Figures are as reported by the company.